AH
Therapeutic Areas
Nanobiotix Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NBTXR3 | Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) | Phase III |
| NBTXR3 + anti-PD-1 | Solid Tumors | Phase I |
| Curadigm Platform Programs | Undisclosed | Discovery/Preclinical |
Leadership Team at Nanobiotix
LL
Laurent Levy, PhD
Chief Executive Officer
BV
Bart Van Rhijn
Chief Financial and Business Officer
LK
Louis Kayitalire, MD
Chief Medical Officer
AL
Anne-Sophie Larivière
Vice President, Strategy & Operational Excellence
BO
Brandon Owens
Vice President, Strategic Marketing and Corporate Communications
GM
Gary M. Phillips, MD
Chairman of Supervisory Board
AH
Alain Herrera, MD
Supervisory Board Member
ES
Enno Spillner
Supervisory Board Member
AG
Anne-Marie Graffin
Supervisory Board Member
MA
Margaret A. Liu, MD
Supervisory Board Member